Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

@article{Gralla1999RecommendationsFT,
  title={Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.},
  author={Richard J. Gralla and David Osoba and Mark G. Kris and Peter Kirkbride and Paul Joseph Hesketh and Lawrence W. Chinnery and Rebecca Anne Clark-Snow and Dawn P Gill and Susan Groshen and Steven M. Grunberg and James M Koeller and Gary R. Morrow and Edith A. Perez and JeffreyH. Silber and David G. Pfister},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1999},
  volume={17 9},
  pages={
          2971-94
        }
}
THE GOAL OF ANTIEMETIC therapy is to prevent nausea and vomiting completely. This goal is achieved for many patients receiving chemotherapy or radiation therapy, and is based on clinical and basic research that has steadily improved the control of emesis over the last 20 years. As therapy has become more effective, it has also become safer, with few side effects associated with the most commonly used regimens. These regimens are convenient for patients to receive and for health care… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 195 CITATIONS, ESTIMATED Infinity% COVERAGE

195 Citations

051015'00'04'09'14'19
Citations per Year
Semantic Scholar estimates that this publication has 195 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 170 REFERENCES

An overview of randomized studies comparing 5 - HT 3 receptor antagonists to conventional antiemetics in the prophylaxis of acute chemotherapy - induced vomit

  • JD Hainsworth
  • Eur J Cancer
  • 1997

Similar Papers

Loading similar papers…